ACCESSION: MSBNK-SMB_Measured-HSA015P0309006
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'EL05_pos_1239': {'bp': 352671.0, 'sum': 464992.0}, 'EL23_pos_1234': {'bp': 299879.0, 'sum': 392951.0}, 'EL07_pos_1231': {'bp': 289985.0, 'sum': 386266.0}, 'EL22_pos_1241': {'bp': 288364.0, 'sum': 430853.0}, 'EL16_pos_1234': {'bp': 267770.0, 'sum': 373660.0}, 'EL24_pos_1240': {'bp': 261447.0, 'sum': 378970.0}, 'EL19_pos_1246': {'bp': 261166.0, 'sum': 358245.0}, 'EL09_pos_1237': {'bp': 247331.0, 'sum': 354182.0}, 'EL15_pos_1233': {'bp': 227049.0, 'sum': 325364.0}, 'EL11_pos_1235': {'bp': 224381.0, 'sum': 291550.0}, 'EL04_pos_1247': {'bp': 211057.0, 'sum': 300117.0}, 'EL06_pos_1244': {'bp': 210834.0, 'sum': 313001.0}, 'EL17_pos_1234': {'bp': 201661.0, 'sum': 300660.0}, 'EL12_pos_1234': {'bp': 180634.0, 'sum': 276735.0}, 'EL10_pos_1238': {'bp': 145304.0, 'sum': 234633.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 309.122514
COMMENT: PRECURSOR_M/Z_STDEV 0.000175
COMMENT: PRECURSOR_IN_MS1 mz 309.122468; int 13.448; delta(ppm) 1.194260
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.807; C10H22N4O3P2; [M+H]+; delta(ppm) -4.806643
COMMENT: PROPOSED_MF SevenGoldenRules 2.798; C18H16N2O3; [M+H]+; delta(ppm) -2.797655
COMMENT: PROPOSED_MF SevenGoldenRules 0.464; C9H26O7P2; [M+H]+; delta(ppm) -0.464112
COMMENT: PROPOSED_MF SevenGoldenRules 4.898; C11H21N2O6P; [M+H]+; delta(ppm) 4.897518
COMMENT: PROPOSED_MF MS-FINDER 2.893; C18H16N2O3; [M+H]+; delta(ppm) -2.791193
COMMENT: PROPOSED_MF MS-FINDER 2.698; C10H20N4O5S; [M+H]+; delta(ppm) -0.683255
COMMENT: PROPOSED_MF MS-FINDER 2.697; C12H17N6O2P; [M+H]+; delta(ppm) 0.552330
COMMENT: PROPOSED_MF MS-FINDER 2.264; C9H26O7P2; [M+H]+; delta(ppm) -0.464590
COMMENT: PROPOSED_MF MS-FINDER 2.091; C10H28O4S3; [M+H]+; delta(ppm) 0.831991
COMMENT: PROPOSED_MF MS-FINDER 1.998; C9H24O9S; [M+H]+; delta(ppm) 3.643244
COMMENT: PROPOSED_MF MS-FINDER 1.854; C11H21N2O6P; [M+H]+; delta(ppm) 4.878838
COMMENT: PROPOSED_MF MS-FINDER 1.528; C11H24N4S3; [M+H]+; delta(ppm) -3.494483
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.464; C10H20N4O5S; [M+H]+; delta(ppm) -0.683255
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.666; C13H17ClN6O; [M+H]+; delta(ppm) -72045.588808
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.847; C18H16N2O3; [M+H]+; delta(ppm) -2.791193
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.149; C15H17FN2O4; [M+H]+; delta(ppm) -6.487603
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.940; C17H21ClO3; [M+H]+; delta(ppm) -72053.069063
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C17H25Br; [M+H]+; delta(ppm) 4.101208
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.825; C10H20N4O5S; [M+H]+; delta(ppm) -0.683255
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.143; C13H17ClN6O; [M+H]+; delta(ppm) -72045.588808
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.024; C18H16N2O3; [M+H]+; delta(ppm) -2.791193
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.005; C17H21ClO3; [M+H]+; delta(ppm) -72053.069063
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.004; C15H17FN2O4; [M+H]+; delta(ppm) -6.487603
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.853; C10H20N4O5S; [M+H]+; delta(ppm) -0.683255
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.189; C14H12N8O; [M+H]+; delta(ppm) 5.895769
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.056; C13H17ClN6O; [M+H]+; delta(ppm) -72045.588808
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.236; C18H16N2O3; [M+H]+; delta(ppm) -2.791193
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.538; C15H17FN2O4; [M+H]+; delta(ppm) -6.487603
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.388; C16H21O4P; [M+H]+; delta(ppm) -8.134540
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.330; C17H21ClO3; [M+H]+; delta(ppm) -72053.069063
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.061; C9H20N4O6Si; [M+H]+; delta(ppm) -171401.351788
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.056; C12H17N6O2P; [M+H]+; delta(ppm) 0.552330
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.936; C11H13FN8O2; [M+H]+; delta(ppm) 2.199295
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.520; C10H20N4O5S; [M+H]+; delta(ppm) -0.683255
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.271; C14H12N8O; [M+H]+; delta(ppm) 5.895769
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.086; C13H17ClN6O; [M+H]+; delta(ppm) -72045.588808
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.017; C18H16N2O3; [M+H]+; delta(ppm) -2.791193
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C11H13FN8O2; [M+H]+; delta(ppm) 2.199295
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.004; C9H20N4O6Si; [M+H]+; delta(ppm) -171401.351788
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.004; C12H17N6O2P; [M+H]+; delta(ppm) 0.552330
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C15H17FN2O4; [M+H]+; delta(ppm) -6.487603
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C17H21ClO3; [M+H]+; delta(ppm) -72053.069063
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C16H21O4P; [M+H]+; delta(ppm) -8.134540
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; WLJKZZOXXCJUGT-UHFFFAOYSA-N; [M+H]+; O=C1C=2C=CC=CC2C(=O)C3=C(N)C(=CC(O)=C13)N4CCCC4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; LWQDVSCNWDIQQR-UHFFFAOYSA-N; [M+H]+; O=C(OC)C1=CC=C(C=C1)NC(=O)C2=CN(C=3C=CC=CC23)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; LWZNOXDAMHBNPT-UHFFFAOYSA-N; [M+H]+; O=C(C=1C=CC=CC1)N2CC3OC=4C=CC=CC4NC(=O)C2C3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MADNATLUHCZDRI-UHFFFAOYSA-N; [M+H]+; O=C1C=2C=C(C=CC2NC(=O)C3N1CC(O)C3)C=4C=CC=CC4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; NWEGEFOQKLXZMC-UHFFFAOYSA-N; [M+H]+; O=C1C=2C=CC=CC2N(C(=O)CN1C)CC(=O)C=3C=CC=CC3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.403; GJUABKCEXOMRPQ-FMQUCBEESA-N; [M+H]+; C.I. Solvent Red 80
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.351; GSYTWFSUSXURDO-UHFFFAOYSA-N; [M+H]+; Azacridone A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.299; NJZPIKQNYWPUTK-MDZDMXLPSA-N; [M+H]+; UNPD230446
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.299; VJNPRSAWVPWWEV-DHZHZOJOSA-N; [M+H]+; UNPD226211
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; SGOOQMRIPALTEL-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; UMGQVUWXNOJOSJ-STGVRZAANA-N; [M+H]+; 2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1R)-1-phenylethyl]-2-propenamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; DLDDSBZRJLMUSB-UHFFFAOYSA-N; [M+H]+; UNPD22597
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; FHIDFFNXBQHJEV-LGWFVXIRNA-N; [M+H]+; UNPD166082
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; WEYXUOGKMWIBSS-UGPWUYPHNA-N; [M+H]+; UNPD7820
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; XJFRKPMKCQUNHM-MDZDMXLPSA-N; [M+H]+; UNPD36373
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.247; XPTOIOVXPXFZCF-LGWFVXIRNA-N; [M+H]+; UNPD85869
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; DLPGRXZQESYPTH-UHFFFAOYSA-N; [M+H]+; 2-(2,3-dioxo-1-indolyl)-N-(2-phenylethyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; KECZBGOYTMZNHZ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-phenyl-4-pyrazolecarboxylic acid (4-methoxyphenyl) ester
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; VGQGTNVENAUVGJ-UHFFFAOYSA-N; [M+H]+; N-(2-ethylphenyl)-5-(3-hydroxyphenyl)-3-isoxazolecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; MWFWGXGLRBDFOQ-WJDWOHSUSA-N; [M+H]+; (3Z)-4-methyl-3-p-anisylidene-1H-1,4-benzodiazepine-2,5-quinone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; WHHHJDGNBVQNAU-UHFFFAOYSA-N; [M+H]+; 7-benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; YPSKWPINAFRQGA-UHFFFAOYSA-N; [M+H]+; 3-benzyl-5-phenylmethoxy-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; AULYIEGZBJYCGY-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-2-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; BZSGALZQKCIGFF-UHFFFAOYSA-N; [M+H]+; 2-[(2-oxo-1,2-dihydroquinolin-4-yl)methyl]-2,3,3a,4,7,7a-hexahydro-1H-isoindole-1,3-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; CEYYMKAFNNDWMD-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-[4-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; CPBSUJGBINQIOE-UHFFFAOYSA-N; [M+H]+; CNP0429591
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; GQMUUCFGHDSOLN-UHFFFAOYSA-N; [M+H]+; 4-methoxy-N-(6-methoxyquinolin-8-yl)benzamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; HIIKTNLDOPHXLM-UHFFFAOYSA-N; [M+H]+; 3-[(6-methoxy-2-methylquinolin-4-yl)amino]benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; HIVLLLMSCJPNTB-UHFFFAOYSA-N; [M+H]+; 2'-(2H-1,3-benzodioxol-5-yl)-1,2-dihydrospiro[indole-3,3'-pyrrolidin]-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; HQHWUUVLWKGRDU-UHFFFAOYSA-N; [M+H]+; CNP0433617
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; IAPGIIOTLDMNNX-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-5-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; IOXLHUBVQAIDGO-UHFFFAOYSA-N; [M+H]+; 2-[(6-methoxy-2-methylquinolin-4-yl)amino]benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; IUYOZVJDDLSNPM-UHFFFAOYSA-N; [M+H]+; 6-(2-methoxyethyl)-5H,6H,6aH,11H-isoindolo[2,1-a]quinazoline-5,11-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; JSZIZINMGOZSDF-UHFFFAOYSA-N; [M+H]+; 7,7-dimethyl-4-(quinolin-6-yl)-1H,2H,3H,4H,5H,7H-furo[3,4-b]pyridine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; KIGPBTYZUXBYOC-UHFFFAOYSA-N; [M+H]+; 2-[(1-benzyl-1H-indol-5-yl)formamido]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; KLUQZQYGFCCIQN-UHFFFAOYSA-N; [M+H]+; 1-(3-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; LONNBQOJYCFAQR-UHFFFAOYSA-N; [M+H]+; CNP0437548
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; LWQDVSCNWDIQQR-UHFFFAOYSA-N; [M+H]+; methyl 4-(1-methyl-1H-indole-3-amido)benzoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; LWZNOXDAMHBNPT-UHFFFAOYSA-N; [M+H]+; 12-benzoyl-2-oxa-9,12-diazatricyclo[9.2.1.0?,?]tetradeca-3,5,7-trien-10-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; MADNATLUHCZDRI-UHFFFAOYSA-N; [M+H]+; 5-hydroxy-13-phenyl-3,9-diazatricyclo[8.4.0.0?,?]tetradeca-1(14),10,12-triene-2,8-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; NWEGEFOQKLXZMC-UHFFFAOYSA-N; [M+H]+; 4-methyl-1-(2-oxo-2-phenylethyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; OBBYLBAQSYGCOE-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; OGEPSAZZTXQECM-UHFFFAOYSA-N; [M+H]+; 4-{[(1-methyl-1H-indol-4-yl)formamido]methyl}benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; OHWUOYUHWJMINH-UHFFFAOYSA-N; [M+H]+; 1-(4-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; OUEWFLQNABACDL-UHFFFAOYSA-N; [M+H]+; N-benzyl-2-imino-6-methoxy-2H-chromene-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; PERULPAGJLYZOA-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-[1-(hydroxyimino)-1,2,3,4-tetrahydronaphthalen-2-yl]-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; PMQYVKPJMFQFJY-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyphenyl)-1H,2H,3H,5H,10H,10aH-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; RMAYWRVTTBOATE-UHFFFAOYSA-N; [M+H]+; 2-{3-[1-(4-methoxyphenyl)prop-1-en-2-yl]-1,2,4-oxadiazol-5-yl}phenol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; SHNSOHCVBLFRCR-UHFFFAOYSA-N; [M+H]+; 3-(1-hydroxyethyl)-6H,7H,12H-5??-indolo[2,3-a]quinolizin-5-ylium-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; UIAYVPVWXXVEGZ-UHFFFAOYSA-N; [M+H]+; 6-(3-hydroxypropyl)-5H,6H,6aH,11H-isoindolo[2,1-a]quinazoline-5,11-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; UYIXDSZCKXBFEK-UHFFFAOYSA-N; [M+H]+; 3-[2-(4-nitrophenyl)ethoxy]-2-phenylbut-2-enenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; VQQPGGPRSKOZRP-UHFFFAOYSA-N; [M+H]+; 2-(4-methoxyphenyl)-1H,2H,3H,5H,10H,10aH-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; WLJKZZOXXCJUGT-UHFFFAOYSA-N; [M+H]+; 1-amino-4-hydroxy-2-(pyrrolidin-1-yl)-9,10-dihydroanthracene-9,10-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; WOBVGRWSRWTFKX-UHFFFAOYSA-N; [M+H]+; 1-[(3-methoxyphenyl)amino]-4-methyl-1H,3H,4H-furo[3,4-b]indol-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; WPBCXLCJWLNDPV-UHFFFAOYSA-N; [M+H]+; 3-(1H-indol-3-yl)-2-(phenylformamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; YGLNAHYGXYDDTD-UHFFFAOYSA-N; [M+H]+; 4-(4-oxo-2-propyl-3,4-dihydroquinazolin-3-yl)benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; YPIZAXIOTLYDIP-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-4-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; YRMMNFZTLRYVJP-UHFFFAOYSA-N; [M+H]+; ethyl 2-(1-oxo-4-phenyl-1,2-dihydrophthalazin-2-yl)acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; ZWCWTOMXQFQEDN-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-[3-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.195; ZZQHNBGRWRQWFI-UHFFFAOYSA-N; [M+H]+; 2-cyano-3-(3,4-dihydroxyphenyl)-N-(2-phenylethyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GSYTWFSUSXURDO-UHFFFAOYSA-N; [M+H]+; Azacridone A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.915; GJUABKCEXOMRPQ-FMQUCBEESA-N; [M+H]+; C.I. Solvent Red 80
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.780; SHNSOHCVBLFRCR-UHFFFAOYSA-N; [M+H]+; 3-(1-hydroxyethyl)-6H,7H,12H-5??-indolo[2,3-a]quinolizin-5-ylium-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.167; WHHHJDGNBVQNAU-UHFFFAOYSA-N; [M+H]+; 7-benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.163; MADNATLUHCZDRI-UHFFFAOYSA-N; [M+H]+; 5-hydroxy-13-phenyl-3,9-diazatricyclo[8.4.0.0?,?]tetradeca-1(14),10,12-triene-2,8-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.146; IUYOZVJDDLSNPM-UHFFFAOYSA-N; [M+H]+; 6-(2-methoxyethyl)-5H,6H,6aH,11H-isoindolo[2,1-a]quinazoline-5,11-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.146; UIAYVPVWXXVEGZ-UHFFFAOYSA-N; [M+H]+; 6-(3-hydroxypropyl)-5H,6H,6aH,11H-isoindolo[2,1-a]quinazoline-5,11-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.132; LWZNOXDAMHBNPT-UHFFFAOYSA-N; [M+H]+; 12-benzoyl-2-oxa-9,12-diazatricyclo[9.2.1.0?,?]tetradeca-3,5,7-trien-10-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.127; YRMMNFZTLRYVJP-UHFFFAOYSA-N; [M+H]+; ethyl 2-(1-oxo-4-phenyl-1,2-dihydrophthalazin-2-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.124; JSZIZINMGOZSDF-UHFFFAOYSA-N; [M+H]+; 7,7-dimethyl-4-(quinolin-6-yl)-1H,2H,3H,4H,5H,7H-furo[3,4-b]pyridine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.121; PERULPAGJLYZOA-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-[1-(hydroxyimino)-1,2,3,4-tetrahydronaphthalen-2-yl]-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.114; NJZPIKQNYWPUTK-MDZDMXLPSA-N; [M+H]+; UNPD230446
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.114; VJNPRSAWVPWWEV-DHZHZOJOSA-N; [M+H]+; UNPD226211
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.114; XJFRKPMKCQUNHM-MDZDMXLPSA-N; [M+H]+; UNPD36373
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.113; WPBCXLCJWLNDPV-UHFFFAOYSA-N; [M+H]+; 3-(1H-indol-3-yl)-2-(phenylformamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.103; KLUQZQYGFCCIQN-UHFFFAOYSA-N; [M+H]+; 1-(3-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.103; OHWUOYUHWJMINH-UHFFFAOYSA-N; [M+H]+; 1-(4-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.103; WOBVGRWSRWTFKX-UHFFFAOYSA-N; [M+H]+; 1-[(3-methoxyphenyl)amino]-4-methyl-1H,3H,4H-furo[3,4-b]indol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.050; UYIXDSZCKXBFEK-UHFFFAOYSA-N; [M+H]+; 3-[2-(4-nitrophenyl)ethoxy]-2-phenylbut-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DLPGRXZQESYPTH-UHFFFAOYSA-N; [M+H]+; 2-(2,3-dioxo-1-indolyl)-N-(2-phenylethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KECZBGOYTMZNHZ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-phenyl-4-pyrazolecarboxylic acid (4-methoxyphenyl) ester
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SGOOQMRIPALTEL-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; UMGQVUWXNOJOSJ-STGVRZAANA-N; [M+H]+; 2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1R)-1-phenylethyl]-2-propenamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VGQGTNVENAUVGJ-UHFFFAOYSA-N; [M+H]+; N-(2-ethylphenyl)-5-(3-hydroxyphenyl)-3-isoxazolecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MWFWGXGLRBDFOQ-WJDWOHSUSA-N; [M+H]+; (3Z)-4-methyl-3-p-anisylidene-1H-1,4-benzodiazepine-2,5-quinone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DLDDSBZRJLMUSB-UHFFFAOYSA-N; [M+H]+; UNPD22597
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FHIDFFNXBQHJEV-LGWFVXIRNA-N; [M+H]+; UNPD166082
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WEYXUOGKMWIBSS-UGPWUYPHNA-N; [M+H]+; UNPD7820
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; XPTOIOVXPXFZCF-LGWFVXIRNA-N; [M+H]+; UNPD85869
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YPSKWPINAFRQGA-UHFFFAOYSA-N; [M+H]+; 3-benzyl-5-phenylmethoxy-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AULYIEGZBJYCGY-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-2-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BZSGALZQKCIGFF-UHFFFAOYSA-N; [M+H]+; 2-[(2-oxo-1,2-dihydroquinolin-4-yl)methyl]-2,3,3a,4,7,7a-hexahydro-1H-isoindole-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CEYYMKAFNNDWMD-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-[4-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CPBSUJGBINQIOE-UHFFFAOYSA-N; [M+H]+; CNP0429591
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GQMUUCFGHDSOLN-UHFFFAOYSA-N; [M+H]+; 4-methoxy-N-(6-methoxyquinolin-8-yl)benzamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HIIKTNLDOPHXLM-UHFFFAOYSA-N; [M+H]+; 3-[(6-methoxy-2-methylquinolin-4-yl)amino]benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HIVLLLMSCJPNTB-UHFFFAOYSA-N; [M+H]+; 2'-(2H-1,3-benzodioxol-5-yl)-1,2-dihydrospiro[indole-3,3'-pyrrolidin]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HQHWUUVLWKGRDU-UHFFFAOYSA-N; [M+H]+; CNP0433617
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IAPGIIOTLDMNNX-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-5-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IOXLHUBVQAIDGO-UHFFFAOYSA-N; [M+H]+; 2-[(6-methoxy-2-methylquinolin-4-yl)amino]benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KIGPBTYZUXBYOC-UHFFFAOYSA-N; [M+H]+; 2-[(1-benzyl-1H-indol-5-yl)formamido]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LONNBQOJYCFAQR-UHFFFAOYSA-N; [M+H]+; CNP0437548
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LWQDVSCNWDIQQR-UHFFFAOYSA-N; [M+H]+; methyl 4-(1-methyl-1H-indole-3-amido)benzoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NWEGEFOQKLXZMC-UHFFFAOYSA-N; [M+H]+; 4-methyl-1-(2-oxo-2-phenylethyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; OBBYLBAQSYGCOE-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; OGEPSAZZTXQECM-UHFFFAOYSA-N; [M+H]+; 4-{[(1-methyl-1H-indol-4-yl)formamido]methyl}benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; OUEWFLQNABACDL-UHFFFAOYSA-N; [M+H]+; N-benzyl-2-imino-6-methoxy-2H-chromene-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PMQYVKPJMFQFJY-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyphenyl)-1H,2H,3H,5H,10H,10aH-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RMAYWRVTTBOATE-UHFFFAOYSA-N; [M+H]+; 2-{3-[1-(4-methoxyphenyl)prop-1-en-2-yl]-1,2,4-oxadiazol-5-yl}phenol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VQQPGGPRSKOZRP-UHFFFAOYSA-N; [M+H]+; 2-(4-methoxyphenyl)-1H,2H,3H,5H,10H,10aH-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WLJKZZOXXCJUGT-UHFFFAOYSA-N; [M+H]+; 1-amino-4-hydroxy-2-(pyrrolidin-1-yl)-9,10-dihydroanthracene-9,10-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YGLNAHYGXYDDTD-UHFFFAOYSA-N; [M+H]+; 4-(4-oxo-2-propyl-3,4-dihydroquinazolin-3-yl)benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YPIZAXIOTLYDIP-UHFFFAOYSA-N; [M+H]+; 2-[(1-methyl-1H-indol-4-yl)formamido]-2-phenylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZWCWTOMXQFQEDN-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-[3-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZZQHNBGRWRQWFI-UHFFFAOYSA-N; [M+H]+; 2-cyano-3-(3,4-dihydroxyphenyl)-N-(2-phenylethyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.667; SGOOQMRIPALTEL-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-N,1-dimethyl-2-oxo-N-phenylquinoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.841; GJUABKCEXOMRPQ-UHFFFAOYSA-N; [M+H]+; 1-[(2,5-dimethoxyphenyl)diazenyl]naphthalen-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; OHOKOCUYERJWFG-LFYBBSHMSA-N; [M+H]+; (5E)-5-(5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; GSYTWFSUSXURDO-UHFFFAOYSA-N; [M+H]+; 6-hydroxy-3,3,12-trimethylchromeno[5,6-b][1,7]naphthyridin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; WHHHJDGNBVQNAU-UHFFFAOYSA-N; [M+H]+; 7-benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.621; JDNAIBCYTQGWFC-UHFFFAOYSA-N; [M+H]+; N-[(2-methoxyphenyl)methyl]-5-phenyl-1,2-oxazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.338; MWFWGXGLRBDFOQ-WJDWOHSUSA-N; [M+H]+; (3Z)-3-[(4-methoxyphenyl)methylidene]-4-methyl-1H-1,4-benzodiazepine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.285; DEPZOHWOPVSMGQ-UHFFFAOYSA-N; [M+H]+; 4-(3-oxo-3-phenylpropyl)-1-phenylpyrazolidine-3,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.285; QOSWUOMZYFFFNP-UHFFFAOYSA-N; [M+H]+; 3-[4-[5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.280; HYWITPJGOLMEHL-SEYXRHQNSA-N; [M+H]+; methyl (Z)-4-(2-benzhydrylidenehydrazinyl)-4-oxobut-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.280; YSHZZFGNQUKPQD-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3-diphenyl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.244; UMGQVUWXNOJOSJ-DGGAMASNSA-N; [M+H]+; (E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.206; LFXGGWQGSIEWLR-UHFFFAOYSA-N; [M+H]+; [3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-phenylpyrazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.197; FITUMOSFDCKONA-UHFFFAOYSA-N; [M+H]+; 8-phenyl-5-propan-2-yl-[1,3]dioxolo[4,5-g]quinazolin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.197; SLCFHAGEVYERLB-UHFFFAOYSA-N; [M+H]+; 5,5-dibenzyl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.196; YWOUBJPQERHRGI-UHFFFAOYSA-N; [M+H]+; ethyl 2-[2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.182; GQDWADHQLNKYRV-UHFFFAOYSA-N; [M+H]+; 2-oxo-3-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.181; JIQFQYPZHNSZDA-INIZCTEOSA-N; [M+H]+; cyanomethyl (2S)-2-benzamido-3-phenylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.177; IIVBHUZWOHMSMY-UHFFFAOYSA-N; [M+H]+; 2-[3-(4-methoxyphenyl)-1-phenylpyrazol-4-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.172; VTMGLOBDVHRQIR-UHFFFAOYSA-N; [M+H]+; 5-(1,3-benzodioxol-5-yl)-3,6-dihydro-2H-imidazo[2,1-a]isoquinolin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.171; HGLISOFZJUBYPD-UHFFFAOYSA-N; [M+H]+; 2-(1-ethyl-2-methylindole-3-carbonyl)pyridine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; ZVCFSCXUODRMKI-UHFFFAOYSA-N; [M+H]+; 3-(1-ethyl-2-methylindole-3-carbonyl)pyridine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; PXCXQJUZLKXSCU-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-1-methyl-N-(4-methylphenyl)-2-oxoquinoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; IRODGGOKLWLTLV-UHFFFAOYSA-N; [M+H]+; N-(furan-2-ylmethyl)-N'-(2-methylnaphthalen-1-yl)oxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; PYHAEMUIQKJBKD-UHFFFAOYSA-N; [M+H]+; 3-[3-(4-methoxyphenyl)-3-oxopropyl]quinazolin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; NBUIXPYWAMPNLW-UHFFFAOYSA-N; [M+H]+; 3-(3-methoxyphenyl)-1-(4-methylphenyl)pyrazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; VNWXVSPXKCCXQN-UHFFFAOYSA-N; [M+H]+; 1-benzyl-3-(2-methoxyphenyl)pyrazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; ZZTVBGGOFIFPJC-UHFFFAOYSA-N; [M+H]+; 1-(4-methoxyphenyl)-14,15-dioxa-3,10-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2,4,6,8-tetraene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; GOWFZZBGAMSPLA-UHFFFAOYSA-N; [M+H]+; 3-(3,5-dimethylphenyl)-2-methyl-4-oxoquinazoline-7-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; KNLXMDDCEIBRBJ-UHFFFAOYSA-N; [M+H]+; 1-(3-methoxyphenyl)-14,15-dioxa-3,10-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2,4,6,8-tetraene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; GWZBKYPCIKQSGU-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyphenyl)-14,15-dioxa-3,10-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2,4,6,8-tetraene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; MFCKECNDTFLNNW-UHFFFAOYSA-N; [M+H]+; 7-methoxy-1-phenyl-14,15-dioxa-3,10-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2,4(9),5,7-tetraene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; SYXKAJGHTVDPCQ-UHFFFAOYSA-N; [M+H]+; 6-methoxy-1-phenyl-14,15-dioxa-3,10-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2,4(9),5,7-tetraene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; DDYYUVJVLQNQKS-UHFFFAOYSA-N; [M+H]+; 5-(1,2-diphenylethyl)-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; GEADVLXQLDPRKX-XDHOZWIPSA-N; [M+H]+; 1-[(E)-(4-methoxyphenyl)methylideneamino]-3-phenylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; YCZVLDKFTUFDHP-ZQXPJFHISA-N; [M+H]+; (Z)-4-[(2E)-2-[(2-methylphenyl)-phenylmethylidene]hydrazinyl]-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; ATJWJAKGDZXFEO-ZQXPJFHISA-N; [M+H]+; (Z)-4-[(2E)-2-[(4-methylphenyl)-phenylmethylidene]hydrazinyl]-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.660; MCEYHTDXSIZRJI; [M+H]+; Oprea1_008065
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.591; PXCXQJUZLKXSCU; [M+H]+; Oprea1_002063
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.671; IOXLHUBVQAIDGO; [M+H]+; Oprea1_495106
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.013; SGOOQMRIPALTEL; [M+H]+; Linomide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.137; GQMUUCFGHDSOLN; [M+H]+; Oprea1_345945
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.004; HIIKTNLDOPHXLM; [M+H]+; Oprea1_120413
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.504; LWQDVSCNWDIQQR; [M+H]+; methyl 4-[(1-methylindole-3-carbonyl)amino]benzoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.645; WHHHJDGNBVQNAU; [M+H]+; Lopac-D-044
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.947; CPWJVNXYNLBCHF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.747; YGLNAHYGXYDDTD; [M+H]+; 4-(4-oxo-2-propylquinazolin-3-yl)benzoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.152; VGQGTNVENAUVGJ; [M+H]+; N-(2-ethylphenyl)-5-(3-hydroxyphenyl)-1,2-oxazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.165; GOWFZZBGAMSPLA; [M+H]+; 3-(3,5-dimethylphenyl)-2-methyl-4-oxoquinazoline-7-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.211; OGEPSAZZTXQECM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.891; PYHAEMUIQKJBKD; [M+H]+; 3-[3-(4-methoxyphenyl)-3-oxopropyl]quinazolin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.169; CEYYMKAFNNDWMD; [M+H]+; 2-methyl-N-[4-(4-oxo-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.650; ZWCWTOMXQFQEDN; [M+H]+; 2-methyl-N-[3-(4-oxo-3,1-benzoxazin-2-yl)phenyl]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.135; LYWGEQXCNMMPLU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.474; NWEGEFOQKLXZMC; [M+H]+; 4-methyl-1-phenacyl-3H-1,4-benzodiazepine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.705; YRMMNFZTLRYVJP; [M+H]+; Oprea1_698168
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.289; YTDJHHZYTXVRHA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.445; DLDDSBZRJLMUSB; [M+H]+; N-[2-(4-hydroxyphenyl)ethyl]-2-(1H-indol-3-yl)-2-oxoacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.275; KECZBGOYTMZNHZ; [M+H]+; (4-methoxyphenyl) 5-methyl-1-phenylpyrazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.037; YSHZZFGNQUKPQD; [M+H]+; 1,3-Diphenyl-5-ethylbarbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.796; GJUABKCEXOMRPQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.862; KIGPBTYZUXBYOC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.905; SLCFHAGEVYERLB; [M+H]+; Ambcb5174604
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.344; ZZQHNBGRWRQWFI; [M+H]+; Lopac-T-5193
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.434; UTEGJWUIPAWNBB; [M+H]+; Oprea1_653379
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.616; MWFWGXGLRBDFOQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.550; DDYYUVJVLQNQKS; [M+H]+; Acide (diphenyl-1,2 ethyl)-5 barbiturique
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.814; ZJQDPXONNQFKKC; [M+H]+; 5-Benzyloxybenzyluracil
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.691; VQQPGGPRSKOZRP; [M+H]+; 2-(4-methoxyphenyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.111; PMQYVKPJMFQFJY; [M+H]+; 2-(2-methoxyphenyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.772; UMGQVUWXNOJOSJ; [M+H]+; Tocris-0579
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.132; XJFRKPMKCQUNHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.132; NJZPIKQNYWPUTK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.575; MDTCYTNEBYQKFC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.230; DLPGRXZQESYPTH; [M+H]+; 2-(2,3-dioxoindol-1-yl)-N-phenethylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.892; WPBCXLCJWLNDPV; [M+H]+; Oprea1_321767
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.236; OHOKOCUYERJWFG; [M+H]+; (5E)-5-(5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.530; YXCSLEHSWRLDHG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.812; OUEWFLQNABACDL; [M+H]+; Oprea1_603332
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.006; JIQFQYPZHNSZDA; [M+H]+; L-N-Benzoyl-3-phenylalanine cyanomethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.167; HSFMSVIZAIBADX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.425; YPIZAXIOTLYDIP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.515; AULYIEGZBJYCGY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.118; ALVZESYSOGRMPW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.988; IAPGIIOTLDMNNX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.813; BZSGALZQKCIGFF; [M+H]+; 2-[(2-oxo-4-hydroquinolyl)methyl]-4,7,3a,7a-tetrahydroisoindole-1,3-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.644; VJNPRSAWVPWWEV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.706; RMAYWRVTTBOATE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.498; UYIXDSZCKXBFEK; [M+H]+; 3-[2-(4-nitrophenyl)ethoxy]-2-phenylbut-2-enenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.633; UIAYVPVWXXVEGZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.007; GQDWADHQLNKYRV; [M+H]+; 5-21-08-00031 (Beilstein Handbook Reference)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.653; XPTOIOVXPXFZCF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.034; LFXGGWQGSIEWLR; [M+H]+; [3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-phenylpyrazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.273; GEADVLXQLDPRKX; [M+H]+; N-(p-Methoxybenzylideneimino)-2-phenylsuccinimide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.656; IUYOZVJDDLSNPM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -357.424; FITUMOSFDCKONA; [M+H]+; 8-phenyl-5-propan-2-yl-[1,3]dioxolo[4,5-g]quinazolin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.461; RVFWSUARIUQWER; [M+H]+; 2-[4-(3-methyl-5-oxo-4-phenyl-4H-pyrazol-1-yl)phenyl]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.268; WOBVGRWSRWTFKX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.928; ATJWJAKGDZXFEO; [M+H]+; 2-Butenedioic acid (Z)-, mono(((4-methylphenyl)phenylmethylene)hydrazide)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.960; OBBYLBAQSYGCOE; [M+H]+; 1-(2-hydroxyphenyl)-1,2,3,4-tetrahydrobeta-carboline-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.766; LWZNOXDAMHBNPT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.209; HYWITPJGOLMEHL; [M+H]+; methyl (Z)-4-(2-benzhydrylidenehydrazinyl)-4-oxobut-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.244; OHWUOYUHWJMINH; [M+H]+; 1-(4-hydroxyphenyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -392.849; KLUQZQYGFCCIQN; [M+H]+; 1-(3-hydroxyphenyl)-1,2,3,4-tetrahydrobeta-carboline-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.827; MFCKECNDTFLNNW; [M+H]+; 4,5-Dihydro-8-methoxy-1-phenyl-1,4-epoxy-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -401.068; SYXKAJGHTVDPCQ; [M+H]+; 4,5-Dihydro-9-methoxy-1-phenyl-1,4-epoxy-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -403.340; YCZVLDKFTUFDHP; [M+H]+; 2-Butenedioicacid (Z)-, mono[[(2-methylphenyl)phenylmethylene]hydrazide]
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -407.289; GWZBKYPCIKQSGU; [M+H]+; 4,5-Dihydro-1-(2-methoxyphenyl)-1,4-epoxy-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -414.531; DEPZOHWOPVSMGQ; [M+H]+; 4-(2-Benzoylethyl)-1-phenyl-3,5-pyrazolidinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -415.972; ZZTVBGGOFIFPJC; [M+H]+; 4,5-Dihydro-1-(4-methoxyphenyl)-1,4-epoxy-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.508; WLJKZZOXXCJUGT; [M+H]+; 1-amino-4-hydroxy-2-pyrrolidin-1-ylanthracene-9,10-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -425.418; MADNATLUHCZDRI; [M+H]+; (6aS,8R)-8-hydroxy-2-phenyl-6a,7,8,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6,11-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -426.928; QOSWUOMZYFFFNP; [M+H]+; 3-[4-[5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]benzonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -426.946; KNLXMDDCEIBRBJ; [M+H]+; 4,5-Dihydro-1-(3-methoxyphenyl)-1,4-epoxy-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -440.731; GRMYUDFDCFVVJZ; [M+H]+; 3-(2-Carboxy-ethyl)-2-(2-phenylamino-vinyl)-benzooxazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -445.974; GSYTWFSUSXURDO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -483.988; PERULPAGJLYZOA; [M+H]+; 3-hydroxy-3-(1-hydroxyimino-3,4-dihydro-2H-naphthalen-2-yl)-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -495.714; HIVLLLMSCJPNTB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -504.383; KIBUXDGHWCBOCZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -511.830; JSZIZINMGOZSDF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -547.395; VTMGLOBDVHRQIR; [M+H]+; 5-(1,3-benzodioxol-5-yl)-3,6-dihydro-2H-imidazo[2,1-a]isoquinolin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -564.855; SHNSOHCVBLFRCR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -599.099; WEYXUOGKMWIBSS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -607.169; FHIDFFNXBQHJEV; [M+H]+; Spiguetidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.209; MCEYHTDXSIZRJI; [M+H]+; Oprea1_008065
COMMENT: CONFIDENCE Level 5: Exact mass of interest 309.122506; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.990
MS$FOCUSED_ION: PRECURSOR_M/Z 309.122506
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1900000000-bd6de67db60e6168d95b
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  59.0313610 25.7382 ? 59.032085 0.6776 8.16 0.2324 15
  61.0106194 13.6589 ? 61.011349 1.3604 5.03 -0.2821 15
  75.0261666 19.2446 ? 75.026907 1.1329 5.65 0.0857 15
  76.0216594 23.6010 ? 76.022398 0.9997 11.94 0.2857 15
  77.0417865 21.9464 ? 77.042523 0.9475 7.89 -0.2179 15
  84.0444402 15.8098 ? 84.045156 1.3802 6.01 0.0490 12
  86.0712566 24.4421 ? 86.071963 0.6506 3.15 0.6993 12
  93.0366924 13.3588 ? 93.037359 1.4618 3.47 0.2879 14
  114.0662321 999.0000 ? 114.066723 0.2981 0.00 1.0000 15
  115.0696585 34.7792 ? 115.070141 0.8951 3.91 0.8505 14
  309.1297419 26.0689 ? 309.130157 1.1354 10.15 -0.5727 11
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  59.031361 25.74 25
  61.010619 13.66 13
  75.026167 19.24 19
  76.021659 23.60 23
  77.041787 21.95 21
  84.044440 15.81 15
  86.071257 24.44 24
  93.036692 13.36 13
  114.066232 999.00 999
  115.069658 34.78 34
  309.129742 26.07 26
//
